TW200640479A - Composition of Chinese medicine - Google Patents

Composition of Chinese medicine

Info

Publication number
TW200640479A
TW200640479A TW094117675A TW94117675A TW200640479A TW 200640479 A TW200640479 A TW 200640479A TW 094117675 A TW094117675 A TW 094117675A TW 94117675 A TW94117675 A TW 94117675A TW 200640479 A TW200640479 A TW 200640479A
Authority
TW
Taiwan
Prior art keywords
vitamin
ginsenoside
composition
chinese medicine
acid
Prior art date
Application number
TW094117675A
Other languages
Chinese (zh)
Inventor
Pin-Hong Li
Original Assignee
Pin-Hong Li
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pin-Hong Li filed Critical Pin-Hong Li
Priority to TW094117675A priority Critical patent/TW200640479A/en
Publication of TW200640479A publication Critical patent/TW200640479A/en

Links

Abstract

The present invention relates to a composition of Chinese medicine used for treating diabetes, and the main formula is the recipe consisting of: ginsenoside Rb1, ginsenoside Rb2, American ginsenoside, Chinese ladiestresses root, whorledleaf Solomonseal Rhizome, lecithin, propolis, Indian Buead, Job's tears, Jerusalem artichoke, Vitamin A, Vitamin D, Vitamin E, Vitamin K1, Vitamin C, Vitamin B1, Vitamin B2, Vitamin B6, Vitamin B12, nicotinic acid, folic acid, pantothenic acid, alkaloid, choline, inositol, iron, iodine, zinc, selenium, chromium, manganese, copper, vanadium, sodium, potassium, calcium, phosphorous, and magnesium.
TW094117675A 2005-05-30 2005-05-30 Composition of Chinese medicine TW200640479A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW094117675A TW200640479A (en) 2005-05-30 2005-05-30 Composition of Chinese medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW094117675A TW200640479A (en) 2005-05-30 2005-05-30 Composition of Chinese medicine

Publications (1)

Publication Number Publication Date
TW200640479A true TW200640479A (en) 2006-12-01

Family

ID=57809882

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094117675A TW200640479A (en) 2005-05-30 2005-05-30 Composition of Chinese medicine

Country Status (1)

Country Link
TW (1) TW200640479A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110229587A1 (en) * 2009-09-24 2011-09-22 Algaecal Distribution Inc. Calcium Supplements for the Treatment of Diabetes
US9308222B2 (en) 2008-01-28 2016-04-12 Yun Kau Tam Formulas comprising highly soluble elements and vitamins for the prevention and amelioration of osteoporosis
CN114748567A (en) * 2022-03-29 2022-07-15 福州和杏健康管理服务有限公司 Blood sugar reducing composition containing antrodia camphorata and preparation method and application thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308222B2 (en) 2008-01-28 2016-04-12 Yun Kau Tam Formulas comprising highly soluble elements and vitamins for the prevention and amelioration of osteoporosis
US20110229587A1 (en) * 2009-09-24 2011-09-22 Algaecal Distribution Inc. Calcium Supplements for the Treatment of Diabetes
CN114748567A (en) * 2022-03-29 2022-07-15 福州和杏健康管理服务有限公司 Blood sugar reducing composition containing antrodia camphorata and preparation method and application thereof

Similar Documents

Publication Publication Date Title
MX2015007479A (en) Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases.
HRP20140398T4 (en) Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy
DOP2012000057A (en) NEW ANTIGONISTS OF PYRIMIDINHEPCIDINE AND TRIAZINHEPCIDINE
WO2008079291A3 (en) Substituted heterocycles and methods of use
MX2012004525A (en) Compounds.
JOP20180036A1 (en) Novel ferroportin-inhibitor salts
WO2017068089A3 (en) Ferroportin inhibitors
TW200724532A (en) Pyrimidinecarboxylic acid derivatives and their use
UA96441C2 (en) Pharmaceutical composition comprosing thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease
TW200745003A (en) Novel compounds
MX2009008531A (en) Nitrogen-containing heterocyclyl ketones and methods of use.
MX2009010407A (en) Fluorinated derivatives of deferiprone.
MY156780A (en) Substituted aromatic compounds and pharmaceutical uses thereof
NZ600390A (en) Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
HRP20050742A2 (en) 3-methyl-2-(3-(2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis
PH12015500860A1 (en) 2-phenyl -5- heterocyclyl -tetrahydro-2h- pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders
WO2011017054A3 (en) Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents
MX2011006006A (en) Compounds, pharmaceutical composition and methods for use in treating metabolic disorders.
EP2257161A4 (en) Ahcy hydrolase inhibitors for treatment of hyper homocysteinemia
TW200640479A (en) Composition of Chinese medicine
Uen et al. Inhibition of aqueous extracts of Solanum nigrum (AESN) on oral cancer through regulation of mitochondrial fission
UA75461U (en) Medicine for the prevention of dental diseases
HK1138264A1 (en) Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands
MX2009013482A (en) [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases.
HRP20050739A2 (en) Cycloalkyl-substituted alkanoic acid derivatives, methods for the production thereof, and use thereof as a medicament